News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
ENRIGHT PATRICK G
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/15/2023 |
4
| ENRIGHT PATRICK G (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns:
| Granted 3,075 shares
@ $0 Sold 1,241 shares
@ $138.1585, valued at
$171.5k
|
|
05/12/2023 |
4
| ENRIGHT PATRICK G (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.
Txns:
| Granted 20,000 options to buy
@ $7.7, valued at
$154k
|
|
02/08/2023 |
4
| ENRIGHT PATRICK G (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.
Txns:
| Bought 1,714,285 shares
@ $7, valued at
$12M
|
|
11/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/31/2022 |
4
| ENRIGHT PATRICK G (Director) has filed a Form 4 on Aptinyx Inc.
Txns:
| Granted 40,000 options to buy
@ $0.5, valued at
$20k
|
|
05/26/2022 |
4
| ENRIGHT PATRICK G (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.
Txns:
| Granted 9,925 options to buy
@ $16.14, valued at
$160.2k
|
|
04/29/2022 |
4
| Longitude Capital Partners III, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.
Txns:
| Disposed of 175,000 shares
@ $0 Disposed of 1,964,771 shares
@ $0 Acquired 5,023 shares
@ $0 Acquired 2,152 shares
@ $0 Acquired 7,175 shares
@ $0 Acquired 588 shares
@ $0 Acquired 252 shares
@ $0 Acquired 840 shares
@ $0 |
|
04/21/2022 |
4
| Longitude Capital Partners III, LLC (10% Owner) has filed a Form 4 on Inozyme Pharma, Inc.
Txns:
| Bought 1,355,000 shares
@ $3.69, valued at
$5M
|
|
04/05/2022 |
4
| ENRIGHT PATRICK G (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.
Txns:
| Bought 333,333 shares
@ $15, valued at
$5M
|
|
02/02/2022 |
4
| Longitude Capital Partners III, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.
Txns:
| Bought 175,000 shares
@ $27, valued at
$4.7M
|
|
01/27/2022 |
4
| Longitude Capital Partners III, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.
Txns:
| Exercised (in-or-at-the-money) 1,477,125 options to buy
@ $13.2, valued at
$19.5M
|
|
08/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/02/2021 |
4
| ENRIGHT PATRICK G (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns:
| Granted 2,246 shares
@ $0 |
|
07/20/2021 |
4
| Longitude Capital Partners II, LLC (10% Owner) has filed a Form 4 on RAPID MICRO BIOSYSTEMS, INC.
Txns:
| Converted 3,344,038 shares
@ $0 Bought 150,000 shares
@ $20, valued at
$3M
Converted 8,774,007 options to buy
@ $0 Converted 5,654,529 options to buy
@ $0 Converted 2,291,665 options to buy
@ $0 Converted 2,500,000 options to buy
@ $0.01, valued at
$25k
Converted 500,000 warrants
@ $0.05, valued at
$25k
Converted 645,160 options to buy
@ $0.01, valued at
$6.5k
Converted 129,032 warrants
@ $0.05, valued at
$6.5k
|
|
06/01/2021 |
4
| ENRIGHT PATRICK G (Director) has filed a Form 4 on Aptinyx Inc.
Txns:
| Granted 40,000 options to buy
@ $2.59, valued at
$103.6k
|
|
05/18/2021 |
4
| ENRIGHT PATRICK G (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.
Txns:
| Converted 2,187,504 shares
@ $0 Bought 909,090 shares
@ $11, valued at
$10M
Converted 2,187,504 preferred shares
@ $0 |
|
05/17/2021 |
4
| ENRIGHT PATRICK G (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.
Txns:
| Granted 9,925 options to buy
@ $11, valued at
$109.2k
|
|
05/11/2021 |
4
| Longitude Capital Partners III, LLC (10% Owner) has filed a Form 4 on Talaris Therapeutics, Inc.
Txns:
| Converted 2,985,775 shares
@ $0 Bought 235,000 shares
@ $17, valued at
$4M
Converted 1,308,410 preferred shares
@ $0 Converted 1,271,027 preferred shares
@ $0 Converted 406,338 preferred shares
@ $0 |
|
04/15/2021 |
4
| Longitude Venture Partners IV, L.P. (10% Owner) has filed a Form 4 on Eargo, Inc.
Txns:
| Disposed of 1,000,000 shares
@ $0 Acquired 5,012 shares
@ $0 |
|
01/05/2021 |
4
| ENRIGHT PATRICK G (Director) has filed a Form 4 on Aptinyx Inc.
Txns:
| Granted 8,149 options to buy
@ $3.46, valued at
$28.2k
|
|
11/18/2020 |
4
| Longitude Capital Partners III, LLC (10% Owner) has filed a Form 4 on 89bio, Inc.
Txns:
| Disposed of 850,000 shares
@ $0 Acquired 2,973 shares
@ $0 Acquired 2,080 shares
@ $0 Acquired 891 shares
@ $0 |
|
11/13/2020 |
4
| ENRIGHT PATRICK G (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns:
| Sold 3,223 shares
@ $145.8102, valued at
$469.9k
Sold 5,083 shares
@ $147.0032, valued at
$747.2k
Sold 1,623 shares
@ $147.6122, valued at
$239.6k
|
|
11/04/2020 |
4
| ENRIGHT PATRICK G (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns:
| Exercised 9,929 options to buy
@ $0 |
|
10/22/2020 |
4
| Longitude Venture Partners IV, L.P. (10% Owner) has filed a Form 4 on Eargo, Inc.
Txns:
| Converted 3,685,358 shares
@ $0 Bought 233,333 shares
@ $18, valued at
$4.2M
Converted 3,685,358 preferred shares
@ $0 |
|
10/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/02/2020 |
4
| ENRIGHT PATRICK G (Director) has filed a Form 4 on Aptinyx Inc.
Txns:
| Granted 8,379 options to buy
@ $3.38, valued at
$28.3k
|
|
09/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/01/2020 |
4
| Longitude Capital Partners III, LLC (10% Owner) has filed a Form 4 on Molecular Templates, Inc.
Txns:
| Sold 2,447 shares
@ $10.7461, valued at
$26.3k
Sold 1,049 shares
@ $10.7461, valued at
$11.3k
|
|
08/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/28/2020 |
4
| Longitude Capital Partners III, LLC (10% Owner) has filed a Form 4 on Inozyme Pharma, Inc.
Txns:
| Converted 2,007,225 shares
@ $0 Converted 187,154 shares
@ $0 Bought 625,000 shares
@ $16, valued at
$10M
Converted 15,000,000 convertible preferred
@ $0 Converted 1,398,600 convertible preferred
@ $0 |
|
07/14/2020 |
4
| Longitude Capital Partners III, LLC (10% Owner) has filed a Form 4 on 89bio, Inc.
Txns:
| Bought 109,090 shares
@ $27.5, valued at
$3M
|
|
07/02/2020 |
4
| ENRIGHT PATRICK G (Director) has filed a Form 4 on Aptinyx Inc.
Txns:
| Granted 5,436 options to buy
@ $4.17, valued at
$22.7k
|
|
05/29/2020 |
4
| ENRIGHT PATRICK G (Director) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns:
| Sold 7,840 shares
@ $0 Granted 15,398 options to buy
@ $17.11, valued at
$263.5k
|
|
|
|
|